Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-25 @ 9:11 PM
Study NCT ID:
NCT04395456
Status:
UNKNOWN
Last Update Posted:
2021-02-21
First Post:
2020-05-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)
Sponsor:
Amyndas Pharmaceuticals S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-19
First Submit QC Date:
None
Study First Post Date:
2020-05-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-19
Last Update Post Date:
2021-02-21
Last Update Post Date Type:
ACTUAL